A

Abingworth Portfolio holdings

AUM $307M
This Quarter Return
+4.4%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
–
AUM
$168M
AUM Growth
+$168M
Cap. Flow
-$644K
Cap. Flow %
-0.38%
Top 10 Hldgs %
93.51%
Holding
17
New
1
Increased
–
Reduced
1
Closed
1

Top Buys

1
VRNA
Verona Pharma
VRNA
$11.3M

Top Sells

1
SIEN
Sientra, Inc.
SIEN
$6.72M
2
ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
$5.2M

Sector Composition

1 Healthcare 99.29%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CRSP icon
1
CRISPR Therapeutics
CRSP
$4.71B
$54.9M 32.61%
1,237,202
– –
SIEN
2
DELISTED
Sientra, Inc.
SIEN
$52.5M 31.22%
2,199,012
-281,482
-11% -$6.72M
VRNA
3
Verona Pharma
VRNA
$9.16B
$11.3M 6.7%
+901,943
New +$11.3M
PRTK
4
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$10M 5.97%
1,041,131
– –
OBSV
5
DELISTED
ObsEva SA Ordinary Shares
OBSV
$7.94M 4.72%
440,000
– –
CHMA
6
DELISTED
Chiasma, Inc. Common Stock
CHMA
$7.49M 4.45%
2,080,595
– –
TARA icon
7
Protara Therapeutics
TARA
$120M
$3.83M 2.28%
2,017,872
– –
ADAP
8
Adaptimmune Therapeutics
ADAP
$15.6M
$3.39M 2.02%
250,000
– –
CBAY
9
DELISTED
Cymabay Therapeutics
CBAY
$3.03M 1.8%
273,417
– –
RARE icon
10
Ultragenyx Pharmaceutical
RARE
$2.89B
$2.91M 1.73%
38,100
– –
CLLS
11
Cellectis
CLLS
$258M
$2.82M 1.68%
100,000
– –
AUPH icon
12
Aurinia Pharmaceuticals
AUPH
$1.58B
$2.66M 1.58%
400,434
– –
SRRA
13
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$2.46M 1.46%
1,444,445
– –
AVEO
14
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$1.32M 0.78%
400,000
– –
IMDZ
15
DELISTED
Immune Design Corp.
IMDZ
$1.2M 0.71%
352,300
– –
OCGN icon
16
Ocugen
OCGN
$319M
$473K 0.28%
888,889
– –
ONCT
17
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
– –
-339,174
Closed -$5.2M